INSEAD Day 4 - 728x90

Google to invest $6.4bn

The investment is its biggest-ever in Germany.

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

Dr Abdullah Asiri chosen member of WHO panel on novel pathogen origins

SAGO will advise WHO on the development of a global framework to define and guide studies into the origins of emerging and re-emerging pathogens of epidemic and pandemic potential, including SARS-CoV-2.
  • Asiri, Saudi Arabia's Deputy Minister for Preventive Health, is one of the 28 members of the Scientific Advisory Group for the Origins of Novel Pathogens.
  • Lebanese Dr Nada Ghosn is another expert from the Middle East chosen as the member.

Dr Abdullah Asiri, Saudi Arabia’s Deputy Minister for Preventive Health, has been chosen as one of the members of the World Health Organization’s Scientific Advisory Group for the Origins of Novel Pathogens (SAGO).

The SAGO includes 28 members of the world’s leading scientists, representing a wide range of disciplines including epidemiology, public health, biology, and other disciplines.

The SAGO will advise WHO on the development of a global framework to define and guide studies into the origins of emerging and re-emerging pathogens of epidemic and pandemic potential, including SARS-CoV-2 (Covid-19).

Dr Nada Ghosn, the head of the Epidemiology Surveillance Program and Medical officer for the Directorate of Prevention at the Ministry of Health, Lebanon, is another member of SAGO from the Middle East.